These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23188178)

  • 1. Fifteen million people on antiretroviral treatment by 2015: treatment as prevention.
    Granich R; Williams B; Montaner J
    Curr Opin HIV AIDS; 2013 Jan; 8(1):41-9. PubMed ID: 23188178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of tuberculosis in people living with HIV.
    Granich R; Akolo C; Gunneberg C; Getahun H; Williams P; Williams B
    Clin Infect Dis; 2010 May; 50 Suppl 3():S215-22. PubMed ID: 20397951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly active antiretroviral treatment for the prevention of HIV transmission.
    Granich R; Crowley S; Vitoria M; Lo YR; Souteyrand Y; Dye C; Gilks C; Guerma T; De Cock KM; Williams B
    J Int AIDS Soc; 2010 Jan; 13():1. PubMed ID: 20205768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration.
    Reid A; Scano F; Getahun H; Williams B; Dye C; Nunn P; De Cock KM; Hankins C; Miller B; Castro KG; Raviglione MC
    Lancet Infect Dis; 2006 Aug; 6(8):483-95. PubMed ID: 16870527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global impact of human immunodeficiency virus and AIDS.
    Gayle HD; Hill GL
    Clin Microbiol Rev; 2001 Apr; 14(2):327-35. PubMed ID: 11292641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues.
    Kumar A; Kumar AM; Gupta D; Kanchar A; Mohammed S; Srinath S; Tripathy S; Rajasekaran S; Chan PL; Swaminathan S; Dewan PK
    Int J Tuberc Lung Dis; 2012 May; 16(5):573-8. PubMed ID: 22507931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis.
    Suthar AB; Klinkenberg E; Ramsay A; Garg N; Bennett R; Towle M; Sitienei J; Smyth C; Daniels C; Baggaley R; Gunneberg C; Williams B; Getahun H; van Gorkom J; Granich RM
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):430-6. PubMed ID: 22640510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From PMTCT to a more comprehensive AIDS response for women: a much-needed shift.
    Eyakuze C; Jones DA; Starrs AM; Sorkin N
    Dev World Bioeth; 2008 Apr; 8(1):33-42. PubMed ID: 18315723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?
    Zachariah R; Teck R; Ascurra O; Gomani P; Manzi M; Humblet P; Nunn P; Salaniponi FM; Harries AD
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):238-47. PubMed ID: 15786885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patching a leaky pipe: the cascade of HIV care.
    Kilmarx PH; Mutasa-Apollo T
    Curr Opin HIV AIDS; 2013 Jan; 8(1):59-64. PubMed ID: 23211779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.
    Lawn SD; Ayles H; Egwaga S; Williams B; Mukadi YD; Santos Filho ED; Godfrey-Faussett P; Granich RM; Harries AD
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):287-95. PubMed ID: 21333094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Part XV. Antiretroviral therapy for human immunodeficiency virus infection.
    Stephens JR; Rathbun RC; Lockhart SM; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Nov; 100(11):417-24. PubMed ID: 18183858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.